This article was originally distributed via PRWeb. PRWeb, WorldNow and this Site make no warranties or representations in connection therewith.
SOURCE: PR Management, Inc.
Eichholz Law Firm reacts to reports that the FDA took 684 days to respond to “serious issues” that were uncovered at the pharmacy associated with the recent meningitis outbreak.
Savannah, Georgia (PRWEB) December 05, 2012
NBC News reports that the U.S. Food and Drug Administration (FDA) waited 684 days “to issue a warning letter after uncovering serious issues at the pharmacy at the center of the deadly U.S. meningitis outbreak, newly released documents showed.” Professionals representing Eichholz Law Firm, a legal organization in Savannah, Georgia, are appalled by this delay in action.
The article reports that “The Centers for Disease Control and Prevention said 34 people have died and 490 have been injured after Framingham, Massachusetts-based NECC shipped thousands of fungus-tainted vials of methylprednisolone acetate to medical facilities throughout the United States.” Instead of easing back pain, as the pharmaceutical was developed to do, it sparked an outbreak of fungal meningitis that has claimed the lives of dozens of victims.
The FDA has reportedly admitted that the gap between the initial inspection of the facility and the issuance of the warning letter was abnormally long; however, Eichholz Law Firm does not believe that this admission makes up for the damage that the tainted pharmaceuticals have caused—and the failure of the FDA to fulfill its responsibility to the American people.
The firm states: “Americans rely on the FDA for oversight and inspection of pharmacies that manufacture drugs intended to help those who are sick and are used to cure deadly diseases. It is alarming to find that state and federal regulators allowed such deplorable conditions to continue unchecked. Even with a recall of infected vials, the scope of this issue may be larger than originally thought. Regulation is essential to holding pharmaceutical companies responsible not only for the effects their drugs have on patients but for the conditions in which they are manufactured. Patients need to know with certainty that the conditions under which medications are manufactured are regulated as stringently as the drug makers themselves. This outbreak of fungal meningitis was preventable. Patients and their loved ones deserve to have their legal rights protected. At Eichholz Law Firm, we are committed to defending those who have been victims of pharmaceutical drugs.”
Eichholz Law Firm encourages the FDA to take the steps necessary to improve efficiency and better protect the American people. The firm recommends that anyone who has been affected by this devastating meningitis outbreak seeks legal assistance.
Founded in Savannah, Georgia, in 1976, Eichholz Law Firm has become an important legal establishment in the community. Today, the firm provides assistance to clients who have suffered from personal injury. The firm also takes on cases involving truck, motorcycle, and automobile accidents, abuse, medical malpractice, negligence, dangerous drugs, wrongful death, product liability, worker’s compensation, and Social Security.
At the firm, a staff of highly trained and qualified legal professionals guides clients through the legal system. To learn more about Eichholz Law Firm, visit http://www.TheJusticeLawyer.com.
For the original version on PRWeb visit: http://www.prweb.com/releases/prweb2012/12/prweb10204353.htm